HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Submit a response Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kopanoff, D E Articles by Johnson, M Search for Related Content PubMed PubMed Citation Articles by Kopanoff, D E Articles by Johnson, M

Recurrent tuberculosis: why do patients develop disease again? A United States Public Health Service cooperative survey.

D E Kopanoff, D E Snider, Jr and M Johnson

Division of Tuberculosis Control, Centers for Disease Control, Atlanta, GA 30333.

In October 1983, a retrospective survey was initiated to determine if patients reported to the Centers for Disease Control as having recurrent tuberculosis truly had recurrent disease and, if so, why they had developed tuberculosis again. Twenty-three health jurisdictions provided information on 800 patients diagnosed as having recurrent tuberculosis during 1981 and 1982. We found that 199 (25 per cent) of the cases did not meet the criteria for recurrent disease. Of the remaining 601 recurrent cases, 20 per cent had no chemotherapy prescribed for their previous episodes of tuberculosis, 20 per cent were prescribed inadequate or inappropriate therapy, and 33 per cent were not compliant with their prescribed therapy regimens. Patients who, during their original episode of tuberculosis, received the major portion of their medical care from physicians in private practice were more compliant than those treated by other health care providers. However, those same patients were more likely to have received inappropriate therapy than patients treated by other providers. Better patient and physician education, closer monitoring, and greater use of preventive therapy and directly observed therapy are necessary to resolve these problems.

This article has been cited by other articles:

				Z. Liu, K. L. Shilkret, and H. M. Ellis Predictors of Sputum Culture Conversion Among Patients With Tuberculosis in the Era of Tuberculosis Resurgence Arch Intern Med, May 24, 1999; 159(10): 1110 - 1116. [Abstract] [Full Text] [PDF]

				S. E. Weis, P. C. Slocum, F. X. Blais, B. King, M. Nunn, G. B. Matney, E. Gomez, and B. H. Foresman The Effect of Directly Observed Therapy on the Rates of Drug Resistance and Relapse in Tuberculosis N. Engl. J. Med., April 28, 1994; 330(17): 1179 - 1184. [Abstract] [Full Text]

				K. F. Gensheimer, I. Joffe, H. L. Israel, T. R. Frieden, and S. W. Dooley Drug-Resistant Tuberculosis in New York City N. Engl. J. Med., July 8, 1993; 329(2): 134 - 135. [Full Text]